HJ
Himanshu Jayantbhai Shah
About Himanshu Jayantbhai Shah
Data last updated:
Himanshu Jayantbhai Shah was an Additional Director at Neucure Lifesciences Private Limited (2022–2023), Whole-Time Director at Eris Lifesciences Limited (2007–2020) and Additional Director at Eris M. J. Biopharm Private Limited (2016), and held 3 more directorships. The companies operate in Healthcare and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neucure Lifesciences Private Limited U24290MP2021PTC054546 | Additional Director | 17 Oct 2022 | 2021 | ₹79.3 Lakh (FY 2025) | Active |
 Eris Lifesciences Limited L24232GJ2007PLC049867 | Whole-Time Director | 27 Jan 2007 | 2007 | ₹5,069 Cr (FY 2025) | Active |
 Eris M. J. Biopharm Private Limited U51397GJ2002PTC112851 | Additional Director | 23 Nov 2016 | 2002 | ₹71.10 Cr (FY 2025) | Active |
 Eris Therapeutics Private Limited U24230GJ2009PTC057670 | Director | 25 Nov 2009 | 2009 | Amalgamated | |
 Orbicular Pharmaceutical Technologies Private Limited U24233TG2008PTC060606 | Additional Director | 01 Apr 2021 | 2008 | ₹272 Cr (FY 2025) | Active |
 Eris Formulations Private Limited U24239GJ2012PTC069999 | Director | 20 Apr 2012 | 2012 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Himanshu Jayantbhai Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Himanshu Jayantbhai Shah
Himanshu Jayantbhai Shah was first appointed on 27 Jan 2007 as Whole-Time Director at Eris Lifesciences Limited. The most recent appointment on record is 17 Oct 2022 at Neucure Lifesciences Private Limited.
Himanshu Jayantbhai Shah held 6 earlier board appointments: Neucure Lifesciences Private Limited (Additional Director, 17 Oct 2022 to 03 Oct 2023); Eris Lifesciences Limited (Whole-Time Director, 27 Jan 2007 to 31 May 2020); Eris M. J. Biopharm Private Limited (Additional Director, 23 Nov 2016 to 12 Dec 2016); Eris Therapeutics Private Limited (Director, 25 Nov 2009 to 06 Aug 2020); Orbicular Pharmaceutical Technologies Private Limited (Additional Director, 01 Apr 2021 to 31 Mar 2022); and 1 more.